Alto Ingredients is trading at $3.76, up 7.43%, after Q3 results and a raised 2026 45Z outlook.

  • November 4 results: $257.9 million in sales and $0.16 per diluted share in net income.
  • Management raised its 2026 outlook to at least $20 million in 45Z tax-credit earnings, net of monetization costs. Company-specific results are the clearest catalyst; the sharply lower broad market does not explain the gain. Shares were still trading at 10:12 a.m. EST; no volume figure was provided.